1. SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria
   Yibo Xue et al, 2021, Nature Communications CrossRef
2. Oncogenic EP300 can be targeted with inhibitors of aldo-keto reductases
   Zimam Mahmud et al, 2019, Biochemical Pharmacology CrossRef
3. Characterization of the Potential Role of NTPCR in Epithelial Ovarian Cancer by Integrating Transcriptomic and Metabolomic Analysis
   Hongkai Shang et al, 2021, Frontiers in Genetics CrossRef
4. Ruanjian Sanjie decoction exhibits antitumor activity by inducing cell apoptosis in breast cancer
   Xiumei Zhao et al, 2017, Oncology Letters CrossRef
5. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
   Y Hu et al, 2016, Cell Death & Disease CrossRef
6. Identification of miRNAs from stem cell derived microparticles in umbilical cord blood
   Angeliki Xagorari et al, 2019, Experimental Hematology CrossRef
7. miR-106b regulates the 5-fluorouracil resistance by targeting Zbtb7a in cholangiocarcinoma
   Dechao Jiao et al, 2017, Oncotarget CrossRef
8. miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
   Evita Maria Lindholm et al, 2019, Molecular Oncology CrossRef
9. MiR-466b-1-3p regulates P-glycoprotein expression in rat cerebral microvascular endothelial cells
   Xiaobo Yang et al, 2017, Neuroscience Letters CrossRef
10. Cluster miRNAs and cancer: Diagnostic, prognostic and therapeutic opportunities
    Shama Prasada Kabekkodu et al, 2020, WIREs RNA CrossRef
11. Effect of MiR-210 on the Chemosensitivity of Breast Cancer by Regulating JAK-STAT Signaling Pathway
    Zeyu Xing et al, 2021, BioMed Research International CrossRef
12. Studies of proteasome inhibition and apoptosis induction in triple‐negative breast cancer cells by novel amino acid–polypyridine–copper complex
    Dongdong Li et al, 2019, Applied Organometallic Chemistry CrossRef
13. GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation
    Jingjing Liu et al, 2019, Breast Cancer Research and Treatment CrossRef
14. The emerging roles of the polycistronic miR-106b∼25 cluster in cancer – A comprehensive review
    Dawid Mehlich et al, 2018, Biomedicine & Pharmacotherapy CrossRef
15. The role of microRNAs on doxorubicin drug resistance in breast cancer
    Khadijeh Jamialahmadi et al, 2021, Journal of Pharmacy and Pharmacology CrossRef
16. MicroRNAs as a clue to overcome breast cancer treatment resistance
    Iris Garrido-Cano et al, 2022, Cancer and Metastasis Reviews CrossRef
17. Pan-Cancer Analysis Reveals Common and Specific Relationships between Intragenic miRNAs and Their Host Genes
    Baohong Liu et al, 2021, Biomedicines CrossRef
18. Genetic dysregulation of EP300 in cancers in light of cancer epigenome control – targeting of p300-proficient and -deficient cancers
    Karolina Gronkowska et al, 2024, Molecular Therapy: Oncology CrossRef
19. miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer
    Shihua Chu et al, 2017, Oncology Reports CrossRef
20. MicroRNA-495/TGF-β/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cells
    Uttom Kumar et al, 2021, Biochemical Pharmacology CrossRef
21. Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
    Muhammad Asaduzzaman et al, 2017, Breast Cancer Research and Treatment CrossRef